โรงพยาบาลศิริราช เป็นโรงพยาบาลมหาวิทยาลัย สังกัดคณะแพทยศาสตร์ศิริราชพยาบาล มหาวิทยาลัยมหิดล เป็นโรงพยาบาลหลวงแห่งแรกของ ประเทศไทย ตั้งอยู่เลขที่ 2 ถนนวังหลัง แขวงศิริราช เขตบางกอกน้อย กรุงเทพมหานคร ติดแม่น้ำเจ้าพระยา ตรงข้ามมหาวิทยาลัยธรรมศาสตร์ ท่าพระจันทร์ เคยเป็นที่ประทับรักษาพระประชวรของพระบาทสมเด็จพระบรมชนกาธิเบศร ...

During the past decade, Siriraj Hospital conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 7 clinical trials were completed, i.e. on average, 18.9% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 3 clinical trials were completed. i.e. 27.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Siriraj Hospital" #1 sponsor was "Mahidol University" with 41 trials, followed by "Siriraj Hospital" with 4 trials sponsored, "Chulalongkorn University" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "TRB Chemedica" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Siriraj Hospital" #1 collaborator was "National Research Council of Thailand" with 4 trials as a collaborator, "Siriraj Hospital" with 4 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Iqvia Pty Ltd" with 2 trials as a collaborator and "Ministry of Health, Thailand" with 2 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 59 trials.

According to Clinical.Site data, the most researched conditions in "Siriraj Hospital" are "Wheat Allergy" (4 trials), "Knee Osteoarthritis" (3 trials), "Complication" (2 trials), "Hepatocellular Carcinoma" (2 trials) and "Humans" (2 trials). Many other conditions were trialed in "Siriraj Hospital" in a lesser frequency.

Most popular intervention types in "Siriraj Hospital" are "Drug" (40 trials), "Device" (8 trials), "Other" (7 trials), "Biological" (4 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Dexmedetomidine" (2 trials), "Etrasimod" (2 trials), "0.25% Bupivacaine" (1 trials) and "0.9% normal saline" (1 trials). Other intervention names were less common.

The vast majority of trials in "Siriraj Hospital" are 63 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 14 active trials in "Siriraj Hospital". 3 are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 37 completed trials in Siriraj Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Siriraj Hospital, 2 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 17 trials that are defined as “Not Applicable".